Sarepta Therapeutics, Inc. (SRPT) revenue

Revenue · fiscal 2025
$2.20B

Sarepta Therapeutics, Inc. (SRPT) reported revenue of $2.20B in fiscal 2025 (the year ended December 31, 2025). That is 15.6% higher than the $1.90B of fiscal 2024. Figures as of 18 Nov 2026, 11:35 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$2.20B
Change on fiscal 2024
+15.6%
Growth, 5 years
+37.0% a year
Growth, 10 years
+111.1% a year
Highest on record
$2.20Bfiscal 2025
Lowest on record
$1.25Mfiscal 2015
Fiscal years on record
122014–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Sarepta Therapeutics, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 37.0% a year; over ten years the rate was 111.1% a year. Across the 12 fiscal years on record (2014–2025), the highest was $2.20B in fiscal 2025 and the lowest $1.25M in fiscal 2015.

History · 12 fiscal years

Revenue by fiscal year

Sarepta Therapeutics, Inc. revenue, year by year

Sarepta Therapeutics, Inc. (SRPT) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$2.20B 15.6% up
2024$1.90B 53.0% up
2023$1.24B 33.3% up
2022$933.01M 52.4% up
2021$612.40M 34.3% up
2020$455.87M 19.7% up
2019$380.83M 26.5% up
2018$301.03M 94.7% up
2017$154.58M 2,751.6% up
2016$5.42M 332.6% up
2015$1.25M 87.2% down
2014$9.76M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on SRPT

Sarepta Therapeutics, Inc., figure by figure

Sarepta Therapeutics, Inc. (SRPT) overview: price, valuation and scorecard

Sarepta Therapeutics, Inc. revenue: questions and answers

What is Sarepta Therapeutics, Inc.'s revenue?

Sarepta Therapeutics, Inc. (SRPT) reported revenue of $2.20B in fiscal 2025 (the year ended December 31, 2025). That is 15.6% higher than the $1.90B of fiscal 2024.

What is the growth rate of Sarepta Therapeutics, Inc.'s revenue?

Over the five fiscal years to 2025 revenue grew at a compound 37.0% a year; over ten years the rate was 111.1% a year.

What are the highest and lowest revenue figures on record for Sarepta Therapeutics, Inc.?

Across the 12 fiscal years on record (2014–2025), the highest was $2.20B in fiscal 2025 and the lowest $1.25M in fiscal 2015.

How is Sarepta Therapeutics, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Sarepta Therapeutics, Inc. it is on record here for 12 fiscal years, 2014 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Sarepta Therapeutics, Inc. (SRPT) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/SRPT/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.